FSPHX
Price
$31.49
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
SHPCX
Price
$14.22
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

FSPHX vs SHPCX

Header iconFSPHX vs SHPCX Comparison
Open Charts FSPHX vs SHPCXBanner chart's image
Fidelity Select Health Care
Price$31.49
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Saratoga Health & Biotechnology C
Price$14.22
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
FSPHX vs SHPCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSPHX vs. SHPCX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a StrongSell and SHPCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 7.41B vs. SHPCX (12.3M). FSPHX (0.00) and SHPCX (0.00) have matching dividends . FSPHX was incepted earlier than SHPCX: FSPHX (43 years) vs SHPCX (25 years). SHPCX is a more actively managed with annual turnover of: 58.00 vs. FSPHX (40.00). FSPHX has a lower initial minimum investment than SHPCX: FSPHX (0) vs SHPCX (250). FSPHX annual gain was more profitable for investors over the last year : 21.16 vs. SHPCX (8.14). FSPHX return over 5 years is better than : 19.77 vs. SHPCX (-12.65).
FSPHXSHPCXFSPHX / SHPCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence43 years25 years-
Gain YTD9.49210.14794%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets7.41B12.3M60,244%
Annual Yield % from dividends0.000.00-
Returns for 1 year21.168.14260%
Returns for 3 years-8.78-8.55103%
Returns for 5 years19.77-12.65-156%
Returns for 10 years40.44-50.73-80%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIELX8.45N/A
N/A
MassMutual International Eq Adm
DSEFX39.72N/A
N/A
Domini Impact Equity Investor
JGLYX19.28N/A
N/A
JPMorgan Small Cap Growth R4
RFEBX87.35-0.26
-0.30%
American Funds Fundamental Invs R2E
DGECX19.84-0.13
-0.65%
BNY Mellon Global Emerging Mkts - C